ClinicalTrials.Veeva

Menu

Soft Tissue Augmentation Around Dental Implant

M

Mansoura University

Status

Completed

Conditions

Gingival Atrophy

Study type

Observational

Funder types

Other

Identifiers

NCT06238427
A11100221

Details and patient eligibility

About

Patients were randomly distributed into two groups (G1 and G2), all patients were treated by a submerged dental implant protocol and free gingival graft (FGG) harvested from the palate as follows:

  • Group 1 (G1), received the FGG two months before implant placement.
  • Group 2 (G2), received the FGG at the time of second-stage surgery (i.e. at the time of healing abutment placement).

All periodontal and radiographic assessments were done by the same operator who was neither involved in the evaluation nor the distribution process. The operator did all the evaluation steps and was completely blinded to the treatment protocol.

Full description

In this investigation, a randomized clinical trial was employed. The patient's randomization was completed by one of the department's senior residents, who was not involved in the trial and was unaware of any relevant treatment plan. A computer-generated randomization list used a randomization table to perform the randomization (SPSS v23.0). Patients were randomly distributed into two groups (G1 and G2), all patients were treated by a submerged dental implant protocol and FGG harvested from the palate. All patients received a thorough description of all procedures involved in the study. Signing a written consent was mandatory for being enrolled in the study. Complete medical and dental histories were recorded for all patients and complete clinical intraoral and extraoral examinations were done for all patients.

Selected patients were questioned about the cause and time of extractions, whether extractions were because of periodontal disease, dental decay or other causes. Previous experiences with dental procedures were also discussed. Intraoral photographs were taken to record the existing condition of teeth and mucosa before implant placement.

Enrollment

20 patients

Sex

All

Ages

21 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 21 years or older
  • Systemic Condition: Healthy
  • Keratinized Mucosa Width: Less than 2mm at the intended implant site
  • Bucco-lingual Bone Width: At least 5.5 mm in a single edentulous space
  • Mesio-distal Distance: At least 7 mm between adjacent teeth in a single edentulous space
  • Minimal Bone Height: Not less than 10 mm
  • Residual Alveolar Ridge: Healthy and well-formed, covered with firm mucosa
  • Periodontal Health: Absence of signs of periodontal bone loss or significant soft tissue .loss in teeth adjacent to the implant site
  • Inter-arch Space: Adequate, exceeding 7 mm

Exclusion criteria

  • Cooperation: Uncooperative patients
  • Pregnancy: Individuals with known pregnancies
  • Parafunctional Habits: Abnormal parafunctional habits such as bruxism and clenching
  • Systemic Illnesses: Patients with systemic illnesses that could disrupt healing
  • Medication: Individuals receiving systemic corticosteroids or other drugs impacting .osseointegration or post-operative healing
  • Smoking: Smokers consuming more than 10 cigarettes per day

Trial design

20 participants in 2 patient groups

Group 1
Description:
Group 1 participants underwent free gingival graft placement two months before implant placement.
Group2
Description:
Group 2 in which the participants underwent the placement of the free gingival graft during the second stage of surgery, specifically at the time of healing abutment placement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems